Diabetic nephropathy and apolipoprotein E2 allele
Diabetic nephropathy and apolipoprotein E2 allele
批准号:
12671128
负责人:
ETO Masaaki
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
先前我们证实载脂蛋白ee2等位基因与糖尿病肾病的进展有关。本研究旨在进一步探讨载脂蛋白E基因多态性、血浆残馀脂蛋白与糖尿病肾病的关系。158例糖尿病病程超过10年的2型糖尿病患者被分为3组载脂蛋白E;载脂蛋白E2 E3/3和E4。测定血脂和残余脂蛋白的血浆水平。通过测量14c -油酸酯掺入胆固醇酯的刺激,估计了载脂蛋白E2甘油三酯(TG)富含脂蛋白(包括残余脂蛋白)对人系膜细胞(HMCs)积累胆固醇酯的影响。apo E2糖尿病患者显性肾病发生率(59.1%)显著高于apo E3/3(34.3%)或apo E4 (8.8%), apo E4糖尿病患者正常蛋白尿发生率(67.6%)显著高于apo E3/3(34.3%)或apo E2(4.5%)。logistic回归分析显示,apo E2和apo E4基因型与显性肾病的比值比分别为10.179 (p=00349)和0.129 (p=0.0028)。apo E2患者血浆中甘油三酯和残留物样脂蛋白颗粒(RLP)-胆固醇和水平显著高于apo E3/3患者,apo E4患者血浆中甘油三酯和残留物样脂蛋白颗粒(RLP)-胆固醇和水平显著低于apo E3/3患者。富含载脂蛋白E2 tg的脂蛋白比富含载脂蛋白E3/3或载脂蛋白E4 tg的脂蛋白更能刺激hmc积累胆固醇酯。载脂蛋白E2是糖尿病肾病的阳性遗传因素,而载脂蛋白E4是糖尿病肾病的阴性遗传因素。富含Apo E2 tg的脂蛋白在hmc中摄取较多。残馀脂蛋白可能在糖尿病肾病的进展中起重要作用。
英文摘要
Previously we demonstrated that the apolipoprotein (apo) E e2 allele is associated with the progression of diabetic nephropathy. The aim of the present study is to further investigate the association between apo E genetic polymorphism, plasma remnant lipoproteins and diabetic nephropathy. One hundred and fifty eight type 2 diabetic patients who had a diabetes duration over 10 years were divided into the 3 apo E groups ; apo E2, E3/3 and E4.Plasma levels of lipids and remnant lipoproteins were measured.The effect of apo E2 triglyceride (TG)-rich lipoproteins including remnant lipoproteins on accumulation of cholesteryl esters by human mesangial cells (HMCs) was estimated by measurement of the stimulation of 14C-oleate incorporation into cholesteryl esters. The frequency of overt nephropathy was significant^ higher in apo E2 diabetic patients (59.1%) than in apo E3/3 (34.3%) or apo E4 patients (8 8%) and the frequency of normoalbuminuria was significantly higher in apo E4 diabetic patients (67 6%) than in apo E3/3 (34.3%) or apo E2 patients (4.5%). Logistical regression analysis showed that odds ratios of apo E2 and apo E4 genotypes for the presence of overt nephropathy were 10.179 (p=00349) and 0.129 (p=0.0028), respectively. Plasma levels of triglyceride and remnant-like lipoprotein particles (RLP)-chol and were significantly higher in apo E2 patients, and significantly lower, n apo E4 patients than in apo E3/3 patients. Apo E2 TG-rich lipoproteins stimulated accumulate of cholesteryl esters by HMCs significantly more than apo E3/3 or apo E4 TG-rich lipoproteins. Apo E2, s a positive genetic factor and apo E4 is a negative genetic factor for diabetic nephropathy. Apo E2 TG-rich lipoproteins were uptaken more avidly by HMCs. Remnant lipoproteins may have an important role in the progression of diabetic nephropathy.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Eto M, Saito M, Kaku K, et al.: "Apolipoprotein E genetic polymorphism, remanat lipoproteins and nephropathy in type 2 diabetic patients."American J Kidney Diseases. (2002)
Eto M、Saito M、Kaku K 等人:“载脂蛋白 E 遗传多态性、残余脂蛋白和 2 型糖尿病患者的肾病。”美国肾脏病杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iwashima Y,Eto M,Hata A,Kaku K,Horiuchi S,Ushibuki F,Sano H,: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem.Biophys.Res.Comm.. 277. 368-380 (2000)
Iwashima Y、Eto M、Hata A、Kaku K、Horiuchi S、Ushibuki F、Sano H,:“培养的人单核细胞来源的巨噬细胞中高级糖基化终末产物诱导清道夫受体的基因表达。”Biochem.Biophys.Res.Comm
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
SaitoM, EtoM, KakuK.: "Remant-like lipoprotein particles (RLP) in type 2 diabetic patients with apolipoprotein E3/3 genotype and with apolipoprotein E2 genotypes"Metabolism. (2002)
SaitoM、EtoM、KakuK.:“具有载脂蛋白 E3/3 基因型和载脂蛋白 E2 基因型的 2 型糖尿病患者中的残余样脂蛋白颗粒 (RLP)”代谢。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
IwashimaY, Eto M, HataA, Kaku K, Horiuchi S, Ushibuki F, SanoH: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem. Biophys. Res. Comm.. 277. 368-380 (2000)
IwashimaY、Eto M、HataA、Kaku K、Horiuchi S、Ushibuki F、SanoH:“在培养的人单核细胞来源的巨噬细胞中,高级糖基化终末产物诱导清道夫受体的基因表达。”Biochem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eto M, Saito M, Kaku K, et al.: "Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan."Clinical Genetics. (2002)
Eto M、Saito M、Kaku K 等人:“日本载脂蛋白 E2/2 基因型的 III 型高脂蛋白血症。”临床遗传学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Risk factors for diabetic nephropathy (apolipoprotein E2 allele and remnant lipoproteins) and drug intervention
-
批准号:19590155
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2007
-
负责人:ETO Masaaki
-
依托单位:
Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathy
-
批准号:14571112
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:2002
-
负责人:ETO Masaaki
-
依托单位:
Study on the significance of apo E in aherosclerosis
-
批准号:05670407
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1993
-
负责人:ETO Masaaki
-
依托单位:
海外基金